[Pharmacotherapy of central oculomotor disorders].Nervenarzt. 2008 Dec; 79(12):1377-8, 1380-2, 1384-5.N
Abstract
Nystagmus causes blurred vision due to oscillopsia, as well as impaired balance. Depending on etiology, additional cerebellar and brain stem signs may occur. We present the current pharmacotherapy of the most common forms of central nystagmus: downbeat nystagmus (DBN), upbeat nystagmus (UBN), acquired pendular nystagmus (APN), and congenital nystagmus (CGN). Recommended medical therapies are aminopyridines (4-AP) for DBN and UBN, gabapentin and memantine for CGN and APN, and baclofen for periodic alternating nystagmus (PAN).
Links
MeSH
Pub Type(s)
Journal Article
Review
Language
ger
PubMed ID
18633586
Citation
Kalla, R, et al. "[Pharmacotherapy of Central Oculomotor Disorders]." Der Nervenarzt, vol. 79, no. 12, 2008, pp. 1377-8, 1380-2, 1384-5.
Kalla R, Spiegel R, Wagner J, et al. [Pharmacotherapy of central oculomotor disorders]. Nervenarzt. 2008;79(12):1377-8, 1380-2, 1384-5.
Kalla, R., Spiegel, R., Wagner, J., Rettinger, N., Jahn, K., & Strupp, M. (2008). [Pharmacotherapy of central oculomotor disorders]. Der Nervenarzt, 79(12), 1377-8, 1380-2, 1384-5. https://doi.org/10.1007/s00115-008-2516-0
Kalla R, et al. [Pharmacotherapy of Central Oculomotor Disorders]. Nervenarzt. 2008;79(12):1377-8, 1380-2, 1384-5. PubMed PMID: 18633586.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - [Pharmacotherapy of central oculomotor disorders].
AU - Kalla,R,
AU - Spiegel,R,
AU - Wagner,J,
AU - Rettinger,N,
AU - Jahn,K,
AU - Strupp,M,
PY - 2008/7/18/pubmed
PY - 2009/4/21/medline
PY - 2008/7/18/entrez
SP - 1377-8, 1380-2, 1384-5
JF - Der Nervenarzt
JO - Nervenarzt
VL - 79
IS - 12
N2 - Nystagmus causes blurred vision due to oscillopsia, as well as impaired balance. Depending on etiology, additional cerebellar and brain stem signs may occur. We present the current pharmacotherapy of the most common forms of central nystagmus: downbeat nystagmus (DBN), upbeat nystagmus (UBN), acquired pendular nystagmus (APN), and congenital nystagmus (CGN). Recommended medical therapies are aminopyridines (4-AP) for DBN and UBN, gabapentin and memantine for CGN and APN, and baclofen for periodic alternating nystagmus (PAN).
SN - 0028-2804
UR - https://www.unboundmedicine.com/medline/citation/18633586/[Pharmacotherapy_of_central_oculomotor_disorders]_
L2 - https://dx.doi.org/10.1007/s00115-008-2516-0
DB - PRIME
DP - Unbound Medicine
ER -